How it’s going: Mark Cuban’s Cost Plus Drugs Company.

“Since I published that first article, Cost Plus Drugs has surpassed 1 million accounts, added over 1,000 low-cost generic drugs to its platform, and formed several strategic partnerships. So, as the company commences its second year of operations on a high note, it’s only fitting to reflect on the progress made and predict what’s in store for the upcoming year.” learn more

Leave a Reply

Your email address will not be published. Required fields are marked *